April 9, 2012 — Thoratec and the U.S. Food and Drug Adminstration (FDA) announced a recent Class 1 recall of the ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
March 29, 2012 —A late-breaking stem cell trial presented at the American College of Cardiology (ACC) Annual Scientific ...
March 19, 2012 – Individuals suffering from chronic heart failure (CHF) can look forward to the appearance of many new ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
March 9, 2012 — Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal ...
March 8, 2012 — Researchers at Sentara Cardiovascular Research Institute are among the top enrollers out of 69 leading ...
March 7, 2012 — Critical Diagnostics announced results from a multi-center study in ambulatory heart failure patients ...
March 7, 2012 — The U.S. Patent and Trademark Office (USPTO) granted biopharmaceutical development company BioLineRx for ...
March 5, 2012 — SynCardia Systems Inc., manufacturer of the world’s first and only U.S. Food and Drug Administration ...
February 27, 2012 – Jarvik Heart Inc. announced conditional U.S. Food and Drug Administration (FDA) approval of its ...
February 24, 2012 — Hospital readmissions continue to be a challenge nationwide. It has been estimated that chronic ...
February 22, 2012 — HeartWare International Inc. announced that a U.S. Food and Drug Administration (FDA) Circulatory ...
February 20, 2012 — Biopharmaceutical company Celladon Corp. this week completed a $43 million equity financing to ...
February 16, 2012 — Few hospitals have as much experience with the Berlin Heart pediatric ventricular assist device (VAD ...
February 2, 2012 — Abiomed Inc. announced that initial clinical data from the safety study for Symphony was presented by ...
January 27, 2012 — A miniature, battery-free, wireless, cardiac implant being developed by a University of Michigan ...